Latest Cash Management News

Page 5 of 26
Invex Therapeutics reported promising preclinical findings on Exenatide’s effects in a human Alzheimer's disease model, alongside a steady cash position and reduced operating outflows in Q3 FY26.
Ada Torres
Ada Torres
24 Apr 2026
Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.
Ada Torres
Ada Torres
23 Apr 2026
Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.
Victor Sage
Victor Sage
21 Apr 2026
EVZ Limited has upgraded its banking facilities by replacing Commonwealth Bank with HSBC, expanding total committed credit to $15.5 million. The new arrangements offer improved terms and greater financial flexibility to support growth across its Energy & Resources and Building Products divisions.
Victor Sage
Victor Sage
17 Apr 2026
Western Mines Group has streamlined its exploration portfolio by divesting non-core tenements and acquiring two promising greenfield nickel-copper sulphide projects along the Yilgarn Craton margins, aligning with its magmatic sulphide expertise.
Maxwell Dee
Maxwell Dee
16 Apr 2026
Zoono Group has boosted its cash receipts by NZ$333,000 this quarter, driven by initial orders worth NZ$585,000 in its fresh food shelf-life extension sector. Despite operating losses, the company expects to sustain operations through signed contracts and inventory.
Ada Torres
Ada Torres
14 Apr 2026
Audeara Ltd has posted its second straight quarter of positive operating cash flow, driven by a record Australian wholesale order and expanding technology licensing deals. The company’s cash balance rose to $1.05 million as it advances global market expansions.
Ada Torres
Ada Torres
14 Apr 2026
Norwood Systems Limited reported a significant revenue increase for the half-year ended December 2025, alongside a widening net loss and strategic progress with Tier-1 telecom customers. The company secured additional funding and advanced its AI-driven voice platforms in collaboration with global hyperscalers.
Sophie Babbage
Sophie Babbage
27 Feb 2026
OM Holdings Limited reported a sharp decline in profit and EBITDA for FY2025, impacted by lower selling prices and market competition, while preparing to complete a major asset disposal valued at US$120 million.
Maxwell Dee
Maxwell Dee
27 Feb 2026
WAM Alternative Assets Limited reported a robust half-year result with net profit surging 40% and declared a 3.0 cents per share interim dividend. The company expanded its private debt exposure and introduced a new treasury solution, underpinning its diversified alternative assets strategy.
Claire Turing
Claire Turing
27 Feb 2026
Atomos Limited has reported a profitable first half of FY26 with revenue up 28%, driven by strong sales and cost discipline. The company reaffirms its full-year guidance, anticipating further growth and positive cash flow in the second half.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Entropy Neurodynamics reports a 14.8% reduction in half-year losses while progressing a pioneering clinical trial for Binge Eating Disorder using its proprietary psychedelic drug TRP-8803. The company also secured $6.1 million in new funding and strategic collaborations to enhance its neuropsychiatry platform.
Ada Torres
Ada Torres
27 Feb 2026

Browse the archive

Full archive